Abstract
Background: Cystatin C (CST3), a strong inhibitor of cysteine proteinases, is freely filtered by the kidney glomerulus and is reabsorbed by the tubules, where it is almost totally catabolized, with the remainder then eliminated in urine. In tubular diseases, it seems sensible to postulate that CST3 degradation would be reduced and consequently an increase in its urinary elimination would be observed.
Methods: We report here the development of an automatic quantitative assay to measure CST3 concentrations in urine using a Behring N-Latex Cystatin C kit on a BNII laser nephelometer. We tested its clinical relevance on several kidney disease patients.
Results: This assay is sensitive (limit of detection 0.008mg/L) and precise (within- and between-day CVs <4%). Reference values for freshly collected urine samples range from 0.03 to 0.18mg/L. Mean urine CST3 concentrations obtained from 52 patients with kidney tubular disease (4.31±3.85mg/L) were significantly higher than those for 60 controls (0.096±0.044mg/L; p<0.0001) and 47 glomerular disease patients (0.106±0.133mg/L; p<0.0001).
Conclusion: Increased urinary CST3 concentrations allow the accurate detection of tubular dysfunction among pure and mixed nephropathies. Because of its ability to be processed on automated clinical chemistry analyzers, this assay could easily be used as an adjunct to the standard panel used to screen kidney pathologies, even in emergency situations.
References
1. Turk B, Turk V, Turk D. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997; 378:141–50.Search in Google Scholar
2. Barrett AJ. The cystatins: small protein inhibitors of cysteine proteinases. Prog Clin Biol Res 1985; 180:105–16.Search in Google Scholar
3. Merz GS, Benedikz E, Schwenk V, Johansen TE, Vogel LK, Rushbrook JI, et al. Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells. J Cell Physiol 1997; 173:423–32.10.1002/(SICI)1097-4652(199712)173:3<423::AID-JCP15>3.0.CO;2-CSearch in Google Scholar
4. Grubb A, Lofberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982; 79:3024–7.10.1073/pnas.79.9.3024Search in Google Scholar
5. Lofberg H, Grubb A, Davidsson L, Kjellander B, Stromblad LG, Tibblin S, et al. Occurrence of gamma-trace in the calcitonin-producing C-cells of simian thyroid gland and human medullary thyroid carcinoma. Acta Endocrinol (Copenh) 1983; 104:69–76.10.1530/acta.0.1040069Search in Google Scholar
6. Lofberg H, Nilsson KE, Stromblad LG, Lasson A, Olsson SO. Demonstration of gamma-trace in normal endocrine cells of the adrenal medulla and in phaeochromocytoma. An immunohistochemical study in monkey, dog and man. Acta Endocrinol (Copenh) 1982; 100:595–8.Search in Google Scholar
7. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37:49–59.10.1258/0004563001901524Search in Google Scholar
8. Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med 2001; 39:850–7.10.1515/CCLM.2001.141Search in Google Scholar
9. Christensson A, Ekberg J, Grubb A, Ekberg H, Lindstrom V, Lilja H. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol 2003; 94:19–27.10.1159/000071287Search in Google Scholar
10. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38(Suppl 1):S20–7.Search in Google Scholar
11. Grubb AO. Cystatin C – properties and use as diagnostic marker. Adv Clin Chem 2000; 35:63–99.10.1016/S0065-2423(01)35015-1Search in Google Scholar
12. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002; 48:699–707.10.1093/clinchem/48.5.699Search in Google Scholar
13. Risch L, Blumberg A, Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 1999; 14:1991–6.10.1093/ndt/14.8.1991Search in Google Scholar
14. Risch L, Huber AR. Assessing the diagnostic accuracy of cystatin C as a marker of impaired glomerular filtration rate. Am J Kidney Dis 2002; 39:661–2.10.1053/ajkd.2002.32162Search in Google Scholar
15. Jacobsson B, Lignelid H, Bergerheim US. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology 1995; 26:559–64.10.1111/j.1365-2559.1995.tb00275.xSearch in Google Scholar
16. Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002; 323:121–8.10.1016/S0009-8981(02)00177-8Search in Google Scholar
17. Han WK, Bonventre JV. Biologic markers for the early detection of acute kidney injury. Curr Opin Crit Care 2004; 10:476–82.10.1097/01.ccx.0000145095.90327.f2Search in Google Scholar
18. Tencer J, Thysell H, Andersson K, Grubb A. Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at –20°C. Scand J Urol Nephrol 1997; 31:67–71.10.3109/00365599709070305Search in Google Scholar
19. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43:1016–22.10.1093/clinchem/43.6.1016Search in Google Scholar
20. Herget-Rosenthal S, Poppen D, Husing J, Marggraf G, Pietruck F, Jakob HG, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50:552–8.10.1373/clinchem.2003.027763Search in Google Scholar
21. Lofberg H, Grubb AO. Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979; 39:619–26.10.3109/00365517909108866Search in Google Scholar
22. Thielemans N, Lauwerys R, Bernard A. Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron 1994; 66:453–8.10.1159/000187863Search in Google Scholar
23. Tkaczyk M, Nowicki M, Lukamowicz J. Increased cystatin C concentration in urine of nephrotic children. Pediatr Nephrol 2004; 19:1278–80.10.1007/s00467-004-1566-1Search in Google Scholar
24. Hosaka B, Park SI, Felipe CR, Garcia RG, Machado PG, Pereira AB, et al. Predictive value of urinary retinol binding protein for graft dysfunction after kidney transplantation. Transplant Proc 2003; 35:1341–3.10.1016/S0041-1345(03)00380-4Search in Google Scholar
25. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43:405–14.10.1053/j.ajkd.2003.10.040Search in Google Scholar
26. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365:1231–8.10.1016/S0140-6736(05)74811-XSearch in Google Scholar
27. Conti M, Zater M, Lallali K, Durrbach A, Moutereau S, Manivet P, et al. Absence of circadian variations in urine cystatin C allows its use on urinary samples. Clin Chem 2005; 51:272–3.10.1373/clinchem.2004.039123Search in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
